Condition: Oral Cancer
Intervention: Combination Product: Photodynamic Therapy
Sponsors: Massachusetts General Hospital; Jawaharlal Nehru Medical College; National Cancer Institute (NCI)
Recruiting
https://ift.tt/2OS07vA
Αρχειοθήκη ιστολογίου
-
▼
2023
(256)
-
▼
Φεβρουαρίου
(140)
-
▼
Φεβ 19
(17)
- Implementable Deep Learning for Multi‐sequence Pro...
- An evaluation of mechanical and biophysical skin p...
- Multifunctional Two-Dimensional Bi2Se3 Nanodiscs f...
- An integrated strategy to identify COVID‐19 causal...
- Downregulation of miR‐193a/b‐3p during HPV‐induced...
- Monitoring of SARS‐CoV‐2 concentration and circula...
- Pustular psoriasis in Malaysia: A review of the Ma...
- The ability of magnetic resonance imaging to predi...
- Nuclear membrane irregularity in high‐grade urothe...
- Impact of Exercise and Detraining on Signs of Pube...
- LRRK2 Inhibition by BIIB122 in Healthy Participant...
- Spermidine reduced neuropathic pain in chronic con...
- Xenogeneic collagen matrix versus connective tissu...
- Tixagevimab/Cilgavimab Treatment and Cardiovascula...
- Recombinant measles virus encoding the spike prote...
- Characterization of protein-based risk signature t...
- Acute Posterior Multifocal Placoid Pigment Epithel...
-
▼
Φεβ 19
(17)
- ► Ιανουαρίου (116)
-
▼
Φεβρουαρίου
(140)
-
►
2022
(1695)
- ► Δεκεμβρίου (78)
- ► Σεπτεμβρίου (142)
- ► Φεβρουαρίου (155)
-
►
2021
(5507)
- ► Δεκεμβρίου (139)
- ► Σεπτεμβρίου (333)
- ► Φεβρουαρίου (628)
-
►
2020
(1810)
- ► Δεκεμβρίου (544)
- ► Σεπτεμβρίου (32)
- ► Φεβρουαρίου (28)
-
►
2019
(7684)
- ► Δεκεμβρίου (18)
- ► Σεπτεμβρίου (53)
- ► Φεβρουαρίου (2841)
- ► Ιανουαρίου (2803)
-
►
2018
(31838)
- ► Δεκεμβρίου (2810)
- ► Σεπτεμβρίου (2870)
- ► Φεβρουαρίου (2420)
- ► Ιανουαρίου (2395)
-
►
2017
(31987)
- ► Δεκεμβρίου (2460)
- ► Σεπτεμβρίου (2605)
- ► Φεβρουαρίου (2785)
- ► Ιανουαρίου (2830)
-
►
2016
(5308)
- ► Δεκεμβρίου (2118)
- ► Σεπτεμβρίου (877)
- ► Φεβρουαρίου (41)
- ► Ιανουαρίου (39)
Αλέξανδρος Γ. Σφακιανάκης
ΩτοΡινοΛαρυγγολόγος
Αναπαύσεως 5
Άγιος Νικόλαος Κρήτη 72100
2841026182
6032607174
Δευτέρα 20 Αυγούστου 2018
Safety, Preliminary Efficacy and PK of Isatuximab (SAR650984) Alone or in Combination With Atezolizumab in Patients With Advanced Malignancies
Condition: Neoplasm
Interventions: Drug: Isatuximab SAR650984; Drug: Atezolizumab
Sponsor: Sanofi
Recruiting
https://ift.tt/2nSq2b1
Interventions: Drug: Isatuximab SAR650984; Drug: Atezolizumab
Sponsor: Sanofi
Recruiting
https://ift.tt/2nSq2b1
Clinical and Radiographic Outcomes of Distal Metatarsal Metaphyseal Osteotomy for Central Primary Metatarsalgia
Condition: Metatarsalgia Bilateral
Intervention: Procedure: Distal Metatarsal Metaphyseal Osteotomy (DMMO)
Sponsor: University of Padua
Recruiting
https://ift.tt/2OM47xt
Intervention: Procedure: Distal Metatarsal Metaphyseal Osteotomy (DMMO)
Sponsor: University of Padua
Recruiting
https://ift.tt/2OM47xt
Dry Needling vs Dry Needling With ES in Patients With Neck/Shoulder Pain
Conditions: Myofascial Pain; Neck Pain; Shoulder Pain
Interventions: Procedure: Dry needling (DN); Procedure: Dry needling with intramuscular electrical stimulation (DNES)
Sponsor: Kindyle Brennan
Recruiting
https://ift.tt/2nPjTfE
Interventions: Procedure: Dry needling (DN); Procedure: Dry needling with intramuscular electrical stimulation (DNES)
Sponsor: Kindyle Brennan
Recruiting
https://ift.tt/2nPjTfE
Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies
Conditions: B-cell Acute Lymphoblastic Leukemia; Lymphoma; Myeloid Leukemia; Multiple Myeloma; Hepatoma; Gastric Cancer; Pancreatic Cancer; Mesothelioma; Colorectal Cancer; Esophagus Cancer; Lung Cancer; Glioma; Melanoma; Synovial Sarcoma; Ovarian Cancer; Renal Carcinoma
Intervention: Biological: CAR-T cell immunotherapy
Sponsors: Shenzhen BinDeBio Ltd.; The First Affiliated Hospital of Zhengzhou University
Recruiting
https://ift.tt/2OUD6YX
Intervention: Biological: CAR-T cell immunotherapy
Sponsors: Shenzhen BinDeBio Ltd.; The First Affiliated Hospital of Zhengzhou University
Recruiting
https://ift.tt/2OUD6YX
The Children and Adolescents Nasopharyngeal Carcinoma Survivor Study
Condition: NPC Patients
Intervention:
Sponsors: Hai-Qiang Mai,MD,PhD; Affiliated Cancer Hospital & Institute of Guangzhou Medical University; Guangdong Provincial People's Hospital; First Affiliated Hospital of Jinan University; Nanfang Hospital of Southern Medical University; Cancer Hospital of Shantou University; Zhanjiang Cancer Hospital; Affiliated Zhongshan Hospital, Sun Yat-Sen University; First People's Hospital of Foshan; Dongguan People's Hospital; Fifth Affiliated Hospital, Sun Yat-Sen University; Shenzhen Second People's Hospital; Jiangmen Central Hospital; Yuebei People's Hospital; Hunan Cancer Hospital; Cancer Hospital of Guizhou Province; Fudan University; Fujian Cancer Hospital; Wuhan Union Hospital, China; The First Affiliated Hospital of Zhengzhou University; Zhejiang Cancer Hospital; Sichuan Cancer Hospital and Research Institute; Shandong Cancer Hospital and Institute; Jiangsu Cancer Institute & Hospital; Jiangxi Provincial Cancer Hospital; Second Affiliated Hospital of Nanchang University; Cancer Institute and Hospital, Chinese Academy of Medical Sciences; Beijing Cancer Hospital; Cancer Hospital of Guangxi Medical University; Tongji Hospital
Not yet recruiting
https://ift.tt/2nSCWpn
Intervention:
Sponsors: Hai-Qiang Mai,MD,PhD; Affiliated Cancer Hospital & Institute of Guangzhou Medical University; Guangdong Provincial People's Hospital; First Affiliated Hospital of Jinan University; Nanfang Hospital of Southern Medical University; Cancer Hospital of Shantou University; Zhanjiang Cancer Hospital; Affiliated Zhongshan Hospital, Sun Yat-Sen University; First People's Hospital of Foshan; Dongguan People's Hospital; Fifth Affiliated Hospital, Sun Yat-Sen University; Shenzhen Second People's Hospital; Jiangmen Central Hospital; Yuebei People's Hospital; Hunan Cancer Hospital; Cancer Hospital of Guizhou Province; Fudan University; Fujian Cancer Hospital; Wuhan Union Hospital, China; The First Affiliated Hospital of Zhengzhou University; Zhejiang Cancer Hospital; Sichuan Cancer Hospital and Research Institute; Shandong Cancer Hospital and Institute; Jiangsu Cancer Institute & Hospital; Jiangxi Provincial Cancer Hospital; Second Affiliated Hospital of Nanchang University; Cancer Institute and Hospital, Chinese Academy of Medical Sciences; Beijing Cancer Hospital; Cancer Hospital of Guangxi Medical University; Tongji Hospital
Not yet recruiting
https://ift.tt/2nSCWpn
Sudden Sensorineural Hearing Loss Associated with Electronic Cigarette Liquid: The First Case in the Literature
Publication date: Available online 20 August 2018
Source: International Journal of Pediatric Otorhinolaryngology
Author(s): Emine Demir, Sevgi Topal
https://ift.tt/2OQlJYV
Εγγραφή σε:
Αναρτήσεις (Atom)